Marks & Spencer (M&S) launches a new bodysuit priced at £28 that includes padded hip inserts. The item is presented as part of the retailer’s shapewear range, following earlier styles such as waist-cinching shapewear and streamlined bodysuits.
Across the coverage provided, the main emphasis is on the bodysuit’s design feature: side or hip padding intended to give “subtle enhancements” in the hip area. The Daily Mail also frames the launch in the context of a broader online trend, referencing “Ozempic butt,” a term used in social media discussions about changes to body shape among some people using weight-loss injections. However, this framing is not presented as a verified health or scientific claim within the supplied reports; it functions as contextual commentary around consumer demand.
Overall, the outlets agree on what M&S is selling and the key physical feature of the product, while differing in how strongly they tie the launch to wider cultural chatter about body-shape trends.
